These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29220302)

  • 21. Subclassification of pleomorphic sarcomas: How and why should we care?
    Hornick JL
    Ann Diagn Pathol; 2018 Dec; 37():118-124. PubMed ID: 30340082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
    Nascimento AF; Bertoni F; Fletcher CD
    Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.
    Bhalla AD; Landers SM; Singh AK; Landry JP; Yeagley MG; Myerson GSB; Delgado-Baez CB; Dunnand S; Nguyen T; Ma X; Bolshakov S; Menegaz BA; Lamhamedi-Cherradi SE; Mao X; Song X; Lazar AJ; McCutcheon IE; Slopis JM; Ludwig JA; Lev DC; Rai K; Torres KE
    Lab Invest; 2022 Jun; 102(6):658-666. PubMed ID: 35228656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
    Li S; Hong R; Wang X; Yang J
    Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric soft tissue sarcomas.
    Stein-Wexler R
    Semin Ultrasound CT MR; 2011 Oct; 32(5):470-88. PubMed ID: 21963167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Biology of Myxofibrosarcoma: State of the Art and Future Perspectives.
    Sambri A; De Paolis M; Spinnato P; Donati DM; Bianchi G
    Oncol Res Treat; 2020; 43(6):314-322. PubMed ID: 32450554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation
    Panse G; Mito JK; Ingram DR; Wani K; Khan S; Lazar AJ; Doyle LA; Wang WL
    Histopathology; 2021 Jan; 78(2):321-326. PubMed ID: 32735735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application].
    Liao ZC; Zhang C; Liu XY; Ren ZW; Xu J; Zhang CZ; Yang Y; Zhu Z; Yang JL
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):648-653. PubMed ID: 31550853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
    Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Pathologic Characterization of 94 Radiation-Associated Sarcomas: Our Institutional Experience.
    Kao EY; McEwen AE; Aden JK; Schaub SK; Ricciotti RW; Mantilla JG
    Int J Surg Pathol; 2023 Aug; 31(5):532-547. PubMed ID: 35695212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
    Bahrami A; Folpe AL
    Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotypic characterization of high grade pleomorphic sarcomas: a demographic and immunohistochemical study in a major referral center of Pakistan.
    Shah H; Pervez S
    J Pak Med Assoc; 2005 Mar; 55(3):101-4. PubMed ID: 15852744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac sarcomas: an update.
    Orlandi A; Ferlosio A; Roselli M; Chiariello L; Spagnoli LG
    J Thorac Oncol; 2010 Sep; 5(9):1483-9. PubMed ID: 20651614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cutaneous and subcutaneous sarcomas].
    Champeau F; Verola O; Vignon-Pennamen MD
    Ann Chir Plast Esthet; 1998 Aug; 43(4):421-38. PubMed ID: 9926474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma.
    Bartlett EK; Sharma A; Seier K; Antonescu CR; Agaram NP; Jadeja B; Rosenbaum E; Chi P; Brennan MF; Qin LX; Alektiar KM; Singer S
    JCO Precis Oncol; 2022 Oct; 6():e2200087. PubMed ID: 36240470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets.
    Merlini A; Rabino M; Brusco S; Pavese V; Masci D; Sangiolo D; Bironzo P; Scagliotti GV; Novello S; D'Ambrosio L
    Expert Opin Ther Targets; 2024; 28(1-2):17-28. PubMed ID: 38234142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
    Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
    PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.